CMR Surgical Limited, a Cambridge, UK-based company developing, manufacturing and marketing an innovative surgical robotic system, raised £195m ($240m) in Series C funding.
Backers included LGT, Escala Capital Investments, Cambridge Innovation Capital, Watrium, and Zhejiang Silk Road Fund as well as new US investors.
The company intends to use the funds to scale up the business to deliver the Versius® surgical robotic system to hospitals around the world whilst supporting continued research and development, manufacturing and expansion.
Led by Martin Frost, Chief Executive Officer, CMR Surgical develops a robotic system for minimal access surgery, Versius®, which features 3D HD vision, an instrument control and a choice of ergonomic working positions. Biomimicking the human arm, Versius provides dexterity and precision to surgeons.
The company, which received the European CE Mark in March 2019 for the system, now has offices located in four continents, and employs 400 people.